Literature DB >> 2431048

Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.

E Wells, S T Harper, C G Jackson, J Mann, R P Eady.   

Abstract

Large numbers of functional mast cells were obtained by bronchoalveolar lavage (BAL) of Macaca arctoides monkeys that had been infected with the nematode Ascaris suum. These lavage cells, of which 21% were mast cells, released histamine, LTC4, and PGD2 in a concentration-dependent fashion when challenged with ascaris antigen or antibody to human IgE. However, there was no release of histamine when these cells were challenged with compound 48/80. The amount of mediator released was highly dependent on the sensitivity of the cells to immunologic challenge, but was generally in the range of 2 to 5 micrograms histamine (30 to 70% of total), 20 to 80 ng LTC4, and 100 to 300 ng PGD2 per 10(6) mast cells when maximally challenged. Other eicosanoids measured were released only in much smaller quantities. Maximal values were 4 ng LTB4, 2 ng PGE2, and approximately 10 to 20 ng PGF2 alpha per 10(6) mast cells. The amount of LTC4 and PGD2 released correlated with the release of histamine, the calculated regression line indicating that 18 ng LTC4 and 50 ng PGD2 were released per microgram of histamine released. This correlation suggests that the majority of the LTC4 and PGD2 released was probably mast cell-derived. Further support for this conclusion was given by the observation that when lavage cells were fractioned on continuous Percoll gradients, the ability to release LTC4 and PGD2 on immunologic challenge coincided with the peak of mast cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431048

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Airway generation-specific differences in the spatial distribution of immune cells and cytokines in allergen-challenged rhesus monkeys.

Authors:  L A Miller; S D Hurst; R L Coffman; N K Tyler; M Y Stovall; D L Chou; L F Putney; L J Gershwin; E S Schelegle; C G Plopper; D M Hyde
Journal:  Clin Exp Allergy       Date:  2005-07       Impact factor: 5.018

2.  Evaluation of an in vitro degranulation challenge procedure for equine pulmonary mast cells.

Authors:  J E Hare; L Viel; P D Conlon; J S Marshall
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

Review 3.  Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue.

Authors:  F J van Overveld
Journal:  Agents Actions       Date:  1990-04

4.  Development of preclinical models for testing antiasthma drugs.

Authors:  T S Orr
Journal:  Drugs       Date:  1989       Impact factor: 9.546

5.  Mast cell subtypes from human lung tissue: their identification, separation, and functional characteristics.

Authors:  F J van Oveveld; L A Houben; P L Bruijnzeel; J A Raaijmakers; G K Terpstra; J Kreukniet
Journal:  Agents Actions       Date:  1988-04

6.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae).

Authors:  E S Schelegle; L J Gershwin; L A Miller; M V Fanucchi; L S Van Winkle; J P Gerriets; W F Walby; A M Omlor; A R Buckpitt; B K Tarkington; V J Wong; J P Joad; K B Pinkerton; R Wu; M J Evans; D M Hyde; C G Plopper
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 8.  Macaque models of human infectious disease.

Authors:  Murray B Gardner; Paul A Luciw
Journal:  ILAR J       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.